Skip to main content

Study

Probiotics May Improve Amino Acid Levels in Seniors with Alzheimer's

A study found that certain probiotics might help improve serum amino acid levels in older adults with mild to moderate Alzheimer's disease.

Brain HealthGut HealthHealthy AgingMemory Support
Study Credibility: High8.8/10From a trusted journalProperly designed studyResults verified
PublishedOct 2026Last reviewedOct 2026
Email this

Summary

In plain language

Recent research has explored the potential benefits of probiotics for seniors suffering from Alzheimer's disease. In a study involving 60 participants aged 50 to 90, researchers examined the effects of two specific probiotic strains, Lactobacillus rhamnosus and Bifidobacterium longum, on serum amino acid levels. Over a 12-week period, participants receiving these probiotics showed changes in their amino acid profiles, which are important for brain health. This could be promising for cognitive support in Alzheimer's patients. However, more research is needed to confirm these findings and determine the best strains and dosages.

Details

Use the full description to understand the study design, methods, and the limits of the findings.

This study was a 12-week, placebo-controlled trial involving 60 seniors with mild to moderate Alzheimer's disease. Participants were divided into three groups: one received Lactobacillus rhamnosus, another Bifidobacterium longum, and the last a placebo. Researchers measured changes in serum amino acid levels, which can influence brain function.

  • The study found potential improvements in amino acid profiles among those taking probiotics, suggesting cognitive benefits.

  • While promising, the findings are limited by the small sample size and the need for more strain-specific research.

  • Probiotics may offer a dietary approach to support brain health, but seniors should consult their healthcare providers before starting new supplements.

Discuss these findings with your healthcare provider to see if probiotics could be beneficial for you.

Research Quality Score

Scored October 22, 2026 using rubric mq-1.8_2026-07-06.

Assessment

The study scored highly due to its rigorous RCT design, strong bias control measures, and comprehensive statistical analysis. Transparency was ensured through pre-registration and data sharing. However, the lack of replication evidence and unspecified journal quality limited the overall score.

Category Breakdown

CategoryScoreRating
Study design10.0/10
Bias control10.0/10
Statistical methods10.0/10
Reporting completeness10.0/10
Conflicts & funding10.0/10
Replication0.0/10
Relevance to chosen population10.0/10
Journal Reliability5.0/10

Additional Notes

This randomized controlled trial investigated the effects of Lactobacillus rhamnosus and Bifidobacterium longum probiotics on serum amino acid levels in adults with mild to moderate Alzheimer's disease, finding significant increases in amino acids, particularly with B. longum.

Assessed on the study's full text across 8 quality dimensions; conflict-of-interest disclosures were reviewed.

Take the next step

Build a personalized plan using research-backed studies, conditions, and treatments.